SBFM Q1 2022 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$122,645+206.2% YoY

Gross Profit

$62,80051.2% margin

Operating Income

-$1M-997.5% margin

Net Income

-$1M-1008.0% margin

EPS (Diluted)

$-468.98

QoQ Revenue Growth

+44.1%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$13M

Total Liabilities

$95,234

Stockholders' Equity

$13M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$122,645	$40,058	+206.2%
Gross Profit	$62,800	$21,538	+191.6%
Operating Income	-$1M	-$1M	+4.1%
Net Income	-$1M	-$6M	+80.0%